Tag: psychedelics

Iowa House Passes Bill To Legalize Medical Use Of Psilocybin

The Iowa House passed legislation Monday to legalize the use of psilocybin, the psychoactive compound found in “magic mushrooms,” for psychiatric treatment through a state program.

House File 978, passed 84–6, would establish a Psilocybin Production Establishment Licensing Board within the Iowa Department of Health and Human Services (DHHS), operating in a similar fashion to the existing Medical Cannabidiol Advisory Board that oversees Iowa’s medical cannabis program. The board would grant licenses for the production and administration of products with psilocybin to people with certain mental health needs in the state.

The bill also sets new requirements for who can access the substance, including an age 21 restriction and limit of 5,000 patients who can be recommended psilocybin treatment.

Rep. John Wills (R-Spirit Lake), the floor manager for the bill, said he would not have guessed that he would be involved in a bill on psilocybin before this year because “it’s just not something that I’m into.” But he said after learning more about the effectiveness of psilocybin treatment for post-traumatic stress disorder (PTSD), he believed the program will help people suffering in Iowa, like military veterans, law enforcement officers and other groups that face high rates of PTSD.

He said the bill requires people to receive psilocybin in a clinical environment with psychiatric support. In this environment, he said, the drug has been shown to allow people to “relive” their trauma in a controlled, safe space, and be able to resolve or lessen the impacts of PTSD. Wills said he believes this method could help address the high suicide rates of veterans and others suffering from the disorder, and offers a better alternative to other forms of PTSD treatment currently available.

“I will tell you, right now the only option these veterans have, the only option these people with PTSD have, is to be on mind-altering, life-altering drugs for the rest of their life,” Wills said.

Keep reading

Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy

A Texas House committee took testimony on Monday about two bills designed to prepare the state to provide swift access to therapeutic psychedelics in the event of approval from the U.S. Food and Drug Administration (FDA).

One measure, HB 4014, would establish a state-backed study, in collaboration with university researchers, on the use of psychedelics to treat mental health disorders such as PTSD and depression. It would direct officials at the Department of State Health Services (DSHS) to make subsequent recommendations “to ensure patient access to psychedelic therapies” following FDA approval.

The other bill, HB 4813, would dictate that substances reclassified under federal law be similarly controlled under state law.

Members of the House Committee on Public Health heard from sponsors and public commenters at Monday’s hearing but did not take action on either bill.

Supporters said the proposals would work together to minimize delays to military veterans and others who stand to benefit from the potentially life-saving therapy.

“This is going to happen. This is coming,” Rep. John Bucy III (D), sponsor of HB 4014, said of what many described as impending FDA approval of psychedelic therapy. “This is the study bill to make sure we’re ready when it comes to implement.”

Bucy’s measure would establish a state-backed study into the use of psychedelics to treat mental health disorders, such as PTSD and depression, in consultation with researchers at Baylor College of Medicine and the University of Texas at Austin’s Center for Psychedelic Research and Therapy.

The project would include an assessment of clinical trials and published literature into the efficacy of psychedelics—specifically MDMA, psilocybin and ketamine—as a treatment PTSD, depression and other mental health disorders.

Officials would also review FDA actions around the therapies, evaluate treatment guidelines and make recommendations to eventually ensure legal access for Texas patients.

In a subsequent report, due by December 1, 2026, DSHS would need to “recommend legislative or other actions necessary to ensure patient access to psychedelic therapies following approval by the United States Food and Drug Administration, including considerations of provider availability, affordability, accessibility, training and licensure, and other regulatory requirements.”

Keep reading

Nevada Senate Passes Joint Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research

The Nevada Senate has approved a joint resolution that calls on Congress to reschedule certain psychedelics, provide protections for people using the substances in compliance with state law and streamline research.

About a week after the legislation from Sen. Rochelle Nguyen (D) cleared committee, the full chamber passed it in an 18-2 vote on Friday. It now moves to the Assembly for consideration.

Nguyen said on the floor that the proposal “sets forth the argument that certain research and therapeutic trials have demonstrated promising results for the use of these substances in the treatment of disorders such as traumatic brain injury, post-traumatic stress disorder, certain depressive disorders and other mental health conditions.”

“The measure notes the low abuse potential for classic psychedelics and highlights their safety in therapeutic session settings,” she said, adding that “SJR 10 expresses Nevada’s continued support for expanded research opportunities…and urges Congress and the appropriate federal agencies to increase related funding” for psychedelic medicines.

Keep reading

Colorado Governor Could Grant Mass Pardons For Psychedelics-Related Convictions Under Newly Filed Bill

Colorado lawmakers have introduced a bill that would empower the governor to grant pardons to people who’ve been convicted of psychedelics-related offenses, while revising rules for the state’s psychedelics legalization law.

Sen. Matt Ball (D) and Rep. Lisa Feret (D) filed the legislation on Tuesday, proposing reforms to authorize Gov. Jared Polis (D) or future governors to grant mass clemency for people with convictions for low-level possession of substances such as psilocybin, ibogaine and DMT that have since been legalized for adults under state law.

In 2023, Polis called on lawmakers to take steps allowing him to issue mass pardons for people with prior psychedelics convictions as the voter-approved legalization policy was being implemented.

The governor said at the time that he needed the legislature to act to provide him with pardon authority, “so anybody who has something on their criminal record that is now legal can have that expunged and doesn’t hold them back from future employment opportunities.”

In addition to granting the governor that authority, the newly introduced measure would also require the Colorado Department of Public Health and Environment (CDPHE), Department of Revenue (DOR) and Department of Regulatory Agencies (DORA) to “collect information and data related to the use of natural medicine and natural medicine products.”

That would include data on law enforcement activities, adverse health events, consumer protection claims and behavioral impacts related to psychedelics.

“Subject to available appropriations, CDPHE shall also collect relevant data and information related to the use of natural medicine from facilitators and healing centers,” the bill says. “CDPHE is required to create and maintain a database of the information collected.”

The legislation, which is scheduled for a hearing before the Senate Health & Human Services Committee on Wednesday, further amends rules around licensing and ownership of psychedelic healing centers. For example, it removes a requirement for fingerprint background checks for owners and employees of licensed facilities, making it so they would only be subject to a name-based criminal background check.

Keep reading

A trip too far: The LSD experience that blew up the Huxley family

In November 1956, three people gathered in a converted Connecticut barn to take LSD, a powerful psychedelic drug that was legal at the time. 

The children had just been put to bed upstairs. In the converted barn’s main room, Elizabethan ballads drifted through smoke-thick air as someone scattered chrysanthemum petals across a sheepskin rug. The flowers seemed to reanimate in the candlelight, blooming and dying with each flicker. Two of the participants lay hand-in-hand in ecstatic communion, while a third sat rigid and apart, his detachment crumbling into barely contained fury. 

By midnight, everything would shatter. 

One participant spiraled into visions of nuclear war. Another transformed into a 10-foot colossus of feminine power. And in the space between these extremes, a marriage began its quiet collapse. 

The aftershocks would reverberate through three generations of Britain’s most celebrated intellectual family, the Huxleys, leaving wounds that simmered in private letters for more than sixty years. 

It’s fitting that this story should be told on Bicycle Day, the annual commemoration of April 19, 1943, when Swiss chemist Albert Hofmann first rode his bike home under the effects of LSD — and ushered in the modern psychedelic era. Nearly 14 years after that inaugural ride, the drug had drifted from the lab into the lives of artists, seekers and intellectual elites like the Huxleys. 

The trip’s architect was Dr. Humphry Osmond, the psychiatrist who had first guided Aldous Huxley — the author of “Brave New World” and “The Doors of Perception” — in experiments with mescaline. and coined the term “psychedelic.” His subjects that evening were Aldous’ only son, Matthew Huxley; Matthew’s wife, Ellen; and Francis Huxley, Matthew’s cousin and the son of biologist Julian Huxley. 

Keep reading

Florida Senate Passes Bill To Ban Psychedelic Mushroom Spores, As Companion Measure Also Advances In House

Florida’s Senate on Wednesday passed a wide-ranging agricultural bill that contains provisions to outlaw fungal spores that produce mushrooms containing psilocybin or psilocin. The vote came a day after a House committee advanced a companion bill in that chamber.

Senators voted 27–9 to approve SB 700, from Sen. Keith Truenow (R). HB 651 is moving through the House, meanwhile, having advanced out of the Commerce Committee on Tuesday.

The proposed ban on spores of mushrooms that create psilocybin or psilocin is a small part of the roughly 150-page legislation, which would make a variety of adjustments to Florida’s agricultural laws, including around agricultural lands, utilities and wildlife management.

With respect to psychedelic mushrooms, both measures would outlaw transporting, importing, selling or giving away “spores or mycelium capable of producing mushrooms or other material which will contain a controlled substance, including psilocybin or psilocyn, during its lifecycle.”

Violating the proposed law would be a first-degree misdemeanor, carrying a maximum one year in jail and $1,000 fine.

While lawmakers on the Senate floor and House committee spent considerable time debating various other portions of the bills—especially a proposed ban on fluoride in local water supplies—there was no mention of the provision concerning psychedelic mushroom spores.

“This bill at its core is meant to help farmers and consumers and students who want to become farmers one day,” Truenow said ahead of the floor vote.

Psilocybin and psilocin are the two main psychoactive compounds in psychedelic mushrooms. Although spores themselves typically do not contain psilocybin or psilocin, they eventually produce fruiting bodies—mushrooms—that do contain the psychedelic compounds.

Because the spores don’t contain any controlled substances, the federal government deems them legal.

Keep reading

Zelensky’s Troops Injected With Various Party Drugs to ‘Promote Battle Readiness’

Facing a shortage of soldiers and the ravages of war, Ukraine has turned to the animal tranquilizer-turned party drug ketamine, the rave-scene classic MDMA and the lesser known hippy hallucinogen ibogaine to ‘promote battle readiness’. Perhaps more importantly however, by keeping its population comfortably drugged, the soldiers and citizens of Ukraine would, assumably, be less apt to protest the continuation of the war. Instead, they are likely to be satiated by the chemical-induced “Valhalla,” as one drugged Ukrainian solider recently described it.

Fascinatingly, during the Joe Biden administration, the United States Department of Defense (formerly Department of War) funded a study which allowed for the injection of ketamine or fentanyl into non-consenting Americans following a traumatic accident, like a car crash. It enrolled unconscious Americans into forced medical experiments regardless of their willingness to participate. The goal was to further develop treatment modalities for battlefield medical operations, specifically the practice of drugging soldiers and finding out if they develop a drug addiction later. The direct link between the U.S. and Ukrainian militaries became deeply intertwined during the Biden-era, as was exposed by Alex Jones in 2022 and eventually The New York Times in 2025.

The proposal to use wartime Ukraine as a testbed for psychedelic drug abuse was made by Dmytro Gurin, a member of the parliament in Kiev. Gurin is a member of the Servant of the People political party, the same party that the country’s Dictator Vladimir Zelensky is part of. Gurin is also a member of the country’s health committee. Gurin wanted MDMA (the primary drug within ecstasy, a mainstay of the electronic dance music scene) to be administered as a first-line treatment for war-related issues, not as a last-ditch effort to treat soldiers woes.

“He’d like E.U. financial support for Ukraine to develop a nationwide clinical trial to test MDMA-assisted therapy as a first treatment for trauma, rather than as a last resort, as is normally recommended,” Politico said in 2023.

While a drugged military may be a happy military, it may also be a productive military. By reducing trauma from the war via drug abuse, Kiev’s armed forces can make the most out of what manpower they have remaining. Ukraine’s military has been facing staffing shortages since soon after the war began. Conscription teams scour the country abducting young men.

Keep reading

Trump’s Veterans Secretary Had ‘Eye-Opening’ Psychedelics Talk With RFK Jr.—And He Plans To Press Congress To Act

The head of the U.S. Department of Veterans Affairs (VA) says he had an “eye-opening” talk with Robert F. Kennedy Jr., the Trump administration’s top federal health official, about the therapeutic potential of psychedelic medicine. And he intends to press Congress to take action on the issue.

VA Secretary Doug Collins, a former Republican congressman, also said during an interview on the Shawn Ryan Show that was posted this week that he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access.

Collins noted that VA has already been conducting clinical trials into the therapeutic use of psychedelics for veterans with post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), and the initial results show it’s “working,” with “tremendous change” among participants.

The secretary said he and Kennedy, the health and human services secretary, “sat in my office two weeks ago and talked about this very issue,” including how to navigate the regulatory and bureaucratic barriers to freeing up funds to support psychedelics access.

“Because we’re actually a hospital, a healthcare organization, we’re bound by some of the laws that Congress has made that have bound us into what we can use and what we can’t use,” he said, adding that marijuana is a “big example” of an alternative therapy that VA isn’t able to provide under current law.

“You’ve had a lot of congressmen say, ‘We’re not gonna do that. We’re gonna keep it where it’s at’” under the Controlled Substances Act (CSA). “And so that it binds us a little bit.”

Asked for details about his conversation with the HHS secretary, Collins said it was “eye-opening because, of course he is very ‘Make America Healthy Again—getting the food additives out, getting those kind of stuff.”

Keep reading